Confidential access
Built for the next billion-dollar exit window. A$3M to A$5M strategic growth round at approximately A$30M post-money.
Capital funds the United States launch, retention engineering, retail acceleration and the next hero SKU.
Comparable-company references are category timing context, not direct valuation comparables.
The strongest hydration brands are habit brands. Hyro has already turned flavour-led hydration into a subscription engine with lifetime gross-profit economics, not just transactional gross profit.
Reconciled cohort dataset across 19 cohorts, Skio, 2026-05-05. Most recent cohorts, Mar-Apr 2026, n=5,630, project the strongest M36 LTV in the dataset.
Hyro is not just a nice-looking drink brand. The formula, price point, flavour range and subscription economics position it between medical hydration, sports drinks and premium wellness powders.
| Brand | Positioning | Sodium | Added sugar | Cost / serve AU |
|---|---|---|---|---|
| Hyro | Playful performance | 500mg | 0g | ~A$1.07, ~A$0.85 on sub |
| Liquid I.V. | Medical hydration | 510mg | 11g | ~A$2.40 |
| Hydralyte | Sick-day rehydration | 490mg | 2g | ~A$1.50 |
| Gatorade | Sports performance | 270mg | 21g | ~A$3.50 |
| LMNT | Keto / endurance | 1,000mg | 0g | ~A$3.00 |
Source from previous investor deck: brand websites plus Coles/Woolworths shelf checks, April 2026. Investor use: shows Hyro's taste/design premium without a premium cost burden.
This is the chart the redesign should not have lost: controlled compounding, not a one-off spike. The original deck showed revenue scaling while ad spend remained disciplined.
Compound monthly growth across the tracked 24-month window.
Blended ROAS maintained through scale and stockout periods.
Source: Shopify sales by month, cross-checked to NAB Xero P&L. Excludes wholesale and US store. Dec-Jan dip reflects BFCM sellout and Christmas manufacturing closure.
Hyro became structurally subscription-led once the team built the engine properly. April 2026 averaged roughly 94 new subs per day, with peaks above 100.
Source: Skio snapshot, 2026-05-05. Active subscriber trajectory calibrated to reported active base.
The current summary slide keeps the headline metrics. This restores the diligence chart showing the LTV curve crossing CAC early and compounding after.
Source: Skio cohort LTV, April 2024 to April 2026. M0-M16 actual, M17-M36 modelled at observed steady-state churn.
The old deck's strongest investor point: Mar-Apr 2026 cohorts, the largest acquisition months in company history, project above the weighted average LTV rather than degrading with scale.
Source: Skio cohort retention export. Y-axis is percentage of cohort still subscribed.
The previous deck included a P&L view that made the business feel real. This restores it as an investor diligence slide while keeping the branded system.
FY25-26 gross margin ex GST.
Implied annual GP in the current subscriber book.
Source: NAB Xero P&L, July 2025 to March 2026. Shows revenue, gross profit and net profit trend before the raise-funded scale-up.
AU subs compounding, early US launch and Creatine live.
US scaled, wholesale expanded and Creatine compounding.
Multi-channel, multi-market daily-routine platform.
Milestones restored from the previous raise deck. They are operating targets used to frame the next funding event or strategic process, not board-approved forecasts.
This restores the old deck's credibility layer around people and shareholder context without overloading the main investment snapshot.
1.3M+ audience. Co-creator of the hero flavour and a structural distribution partner.
Quade Cooper, Daly Cherry-Evans, Kendrick Louis and athlete network credibility.
Dan Churchill plus a broader founder-led creator-investor network that compounds trust.
The US Shopify Plus store is live. The brand already has proof in Australia. The round gives Hyro the inventory, creator activation and paid media fuel to move properly.
Hyro has an AI operating layer across growth, finance, supply chain, customer experience and founder leverage. This is a margin and speed lever in every function, not a tech bet.
Chief-of-staff layer, execution orchestration and founder leverage.
Paid media, creative intelligence and growth operating rhythm.
Inventory, supply chain, purchasing and operational visibility.
Finance cockpit, customer inbox execution and escalation discipline.
This round is not open to passive capital. The right investor helps Hyro turn a proven Australian subscription engine into a global hydration platform.
Forward-looking statements are working scenarios, not board-approved forecasts. Final round terms subject to definitive documentation, board approval and customary diligence. Unit economics sourced from the Skio cohort LTV pack reconciled against Lifetimely blended CAC and Northbeam corrected spend. All financial figures stated ex GST.